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Abstract
In the United States approximately 10–15% of women consume alcohol (ethanol)
during pregnancy. Even low amounts of ethanol consumption during pregnancy can elicit
long-term consequences. Prenatal experience with as few as 3 drinks has been
associated with increase problem drinking in adulthood. Such effects are corroborated in
rodents; however, the underlying neural adaptations contributing to this effect are not
clear. In the current set of experiments, we investigated whether changes in ethanol
responding following prenatal ethanol exposure involved kappa opioid receptor
activation and expression.
Sprague-Dawley rats were prenatally exposed to low levels of alcohol (1.0 g/kg)
during late gestation (gestational day 17-20: GD17-20) via intragastric intubation of
pregnant dams. Following birth, ethanol intake, kappa and mu opioid-induced place
conditioning, and kappa opioid receptor expression in mesolimbic brain regions was
assessed in infant rats (postnatal day 14-15: PD14-15) that were offspring of dams given
ethanol, vehicle, or untreated, during pregnancy.
Animals exposed to prenatal alcohol drank more alcohol later in life
and exhibited significant changes in the kappa opioid system. While control subjects
found kappa opioid activation aversive, animals exposed to ethanol prenatally exhibited
either no aversion or appetitive responding. Further analysis revealed that synaptosomal
kappa opioid receptor expression was significantly decreased in brain areas implicated
in responding to ethanol. Overall, this data suggests that prenatal ethanol affects kappa
opioid function and expression and that these changes may be involved in increased
drinking later in life.
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1. Introduction
Alcohol abuse is a worldwide concern affecting the lives of millions. While a large
portion of the population drinks with little to no adverse consequences, a substantial
number become dependent and abuse the drug with extremely adverse outcomes.
Experience with alcohol in the womb or during infancy has been show to predispose
individuals to problematic alcohol consumption later in life. Epidemiological studies
confirm that humans exposed prenatally to a moderate amount of ethanol are at risk for
alcohol abuse as adolescents and subsequently as adults (Alati et al., 2006, 2008; Baer
et al., 1998, 2003; Yates et al., 1998).
Preclinical studies seem to confirm these epidemiological results. For example,
studies have shown that rats exposed to 1.0 or 2.0 g/kg ethanol on gestational days 17 –
20 (GD 17 – 20) exhibit enhanced ethanol intake in mid-infancy and adolescence (Arias
& Chotro 2005; Chotro et al., 2007; Chotro & Arias 2003; Molina et al., 1999; Fabio et
al., 2013) and learn conditioned preferences for doses of ethanol that untreated animals
do not find reinforcing (Nizhnikov et al., 2006; Pautassi et al., 2012). Specifically,
prenatal exposure to ethanol (1 or 2 g/kg IG from G17 – 20) increases the range of
ethanol doses that 3-hour-old and 14 day-old rat pups find reinforcing in comparison to
untreated or water exposed controls (Nizhnikov et al., 2006, Pautassi et al., 2012).
A possible mechanism by which these effect might occur has been discussed by
Abate and coworkers (2001, 2004). Their studies revealed that prenatal ethanol
exposure can result in associative learning between the orosensory and the
postabsorptive, reinforcing effects of ethanol. Later re-exposure to the taste or odor of
ethanol may trigger drug seeking and intake. Fabio et al. (2013) found that adolescent
rats that had been exposed to ethanol during late gestation exhibited reduced baseline
levels of c-fos activation in the prefrontal prelimbic area, an area involved in the
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extinction of learned associations. The mechanisms underlying this facilitative effect of
prenatal ethanol on later ethanol intake remain however, largely unknown.
The endogenous opioid system plays a major role in ethanol reinforcement (Herz
1997; Vengeliene et al., 2008; Sommer et al., 2006; Méndez & Morales-Mulia 2008).
General blockade of the opioid system by administration of naltrexone disrupts ethanol
intake and reinforcement in selected and unselected strains of rats and other species
(Stromberg et al., 1998; Goodwin et al., 2001; Kato 2008; Nizhnikov et al., 2009; Barson
et al., 2010), which has led to its application in treatment of alcoholism (Kranzler & Van
Kirk 2001; Pettinati & Rabinowitz 2006). Antagonism of mu and delta opioid systems
also inhibits both ethanol intake and reinforcement in adult and infant rats (Barson et al.,
2010; Hyytiä & Kiianmaa 2001; Lindholm et al., 2001; Mitchell et al., 2005 Nizhnikov et
al., 2009; Pautassi et al., 2011). Moreover, administration of the general opioid
antagonist naloxone to the pregnant, intoxicated dam inhibits the facilitative effect of
prenatal ethanol on subsequent ethanol intake (Miranda-Morales et al., 2010).
The kappa opioid system has also been implicated in ethanol’s motivational
effects. Generally, kappa opioid receptors are present throughout the central nervous
system (Atalli et al., 1990; Leslie & Loughlin, 1992, 1993; Petrillo et al., 1987). Unlike
the mu and delta opioid system, kappa activity appears to mediate the aversive
properties of alcohol during infancy and adulthood in non-dependant rats (Land et al.,
2009; Pillai et al., 1986; Pohorecky et al., 1989). For example, 14-day old rats found
ethanol reinforcing, when assessed in conditioned place or taste preference, only after
blockade of kappa opioid receptors (Pautassi et al., 2012b). Furthermore, selective
kappa agonists attenuate ethanol intake in adult non-dependant rats while antagonists
increase it (Mitchell et al., 2005; Logrip et al., 2009; Sandi et al., 1988; Matsuzawa et al.,
1999; Jamensky & Gianoulakis 1997). Intriguingly, animals which have been made
ethanol dependant show the reverse response to kappa opioid manipulations, i.e. kappa
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antagonists reduce operant responding for and intake of ethanol (Walker & Koob 2008;
Walker et al., 2011; Philpot et al., 2003). This is most likely due to an up-regulation of the
kappa opioid system resulting in increased responding for ethanol’s negative reinforcing
properties, with this effect being reversed by kappa opioid antagonists. Kappa opioid
receptors are positioned pre-synaptically and tend to tonically inhibit dopamine release
in the nucleus accumbens and in the prefrontal cortex via connections to the ventral
tegmental area (see Sunil et al., 2012 for comprehensive review). Thus, changes in the
function of this system (up-regulation) in dependent rats would explain their increased
drinking and the effects of kappa opioid antagonism in these subjects. The above results
are examples of a change in the endogenous opioid system due to experience with
ethanol resulting in increased seeking and drinking of ethanol.

Experiments have shown changes in several opioid systems including the kappa
opioid system after ethanol exposure in adulthood (Rosin et al., 1999; Turchan et al.,
1999; Lindholm et al., 2000; Cowen & Lawrence 2001; Zapata & Shippenberg 2006;
Sirohi et al., 2012). For example, Rosin and colleagues (1999) reported down regulation
of kappa opioid receptor mRNA in the ventral tegmental area (VTA) and nucleus
accumbens (NAc). On the other hand Lindholm et al., (2000) found an upregulation of
Dynorphin-B in the NAc. These results suggest that the function of the kappa opioid
system may change after chronic ethanol exposure during adulthood. We hypothesize
that similar changes may occur after prenatal exposure to ethanol resulting in increased
intake of and reinforcement to ethanol later in life, increasing the likelihood of alcohol
dependence. This possibility is especially intriguing given kappa’s ontogenetic change in
motivational properties (from appetitive to aversive) during the 1st and 2nd postnatal
weeks (Barr GA 1993; Petrov et al., 2006; Bals-Kubik et al., 1993; Varlinskaya et al.,
1996). Specifically, Petrov et al., (2006) reported that newborn infant rats find kappa
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opioid receptor activation appetitive while adults have been shown to clearly find
activation of kappa aversive.
The present study analyzed ethanol intake in preweanling rats following brief
prenatal ethanol exposure during late gestation (Experiment 1). After establishing the
reliability of increased ethanol intake following prenatal exposure to the drug, a
subsequent experiment tested kappa opioid mediation of this phenomenon (Experiment
2). The possibility of prenatal ethanol affecting the motivational properties of both kappa
and mu opioid signaling was then tested in Experiment 3 & 4, via second order
conditioned place preference (Pautassi et al., 2011; 2012).

2. Methods
2.1. Subjects
720 Sprague-Dawley male and female rat pups (postnatal day 14; PD14)
representative of 90 litters, were employed in Experiments 1 through 5. The animals
were PD14 at the start of the experimental procedures. All litters were born and reared at
the Center for Development and Behavioral Neuroscience (Binghamton University,
USA). Two females (at least PD60) were caged with a single male. For the following
week vaginal smears were taken and the day of sperm detection was considered
gestational day 0 (GD0). Births were examined daily and the day of parturition was
considered as postnatal day 0 (PD 0). On PD1 litters were culled to 10 pups (5 males
and 5 females, whenever possible). Pups were housed with the dam in standard
maternity cages with free access to water and food. The colony was kept at 22 – 24 °C
and a 12-hour light-dark cycle was used with light onset occurring at 700 AM. All
procedures were in compliance with the Guide for Care and Use of Laboratory Animals
(National Institutes of Health, 1986) and were also approved by the Institutional Animal
Care and Use Committee within an AAALAC-accredited facility.
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2.2. Prenatal Ethanol Treatment
The procedures were similar to those used in Fabio et al., (2013) and in DíazCenzano & Chotro (2010). From gestational day 17 (GD17) to GD20 a randomly
selected set of dams received daily intragastric (i.g) administrations of ethanol (12.6%
v/v ethanol solution; volume of administration: 0.01 ml/g; dose: 1.0 g/kg); similar volume
of vehicle (tap water), or remained untreated. Previous findings show this procedure
results in fetuses achieving blood ethanol concentrations of approximately 50 mg/dl
(Dominguez et al., 1998). Untreated dams were kept under similar housing conditions as
the previous two groups but did not receive any treatment across GDs 17-20.

2.3 Intraoral Cannulation
Experiments 1 through 4 required cannulation for direct intraoral infusion of water
or ethanol. A piece of polyethylene (PE)-10 tubing (Clay Adams, Parsippany, NJ), 3 cm in
length, was flanged at one end using a heat source. The non-flanged end of the tubing
was tightly fit onto one end of a sharpened and curved stainless-steel wire (0.285 mm
diameter, approximately 4 cm in length). The wire was then inserted gently midline
through the cheek, with the flanged tip resting anteriorly position on the interior portion of
the cheek (Spear et al., 1989; Pautassi et al., 2002). The free end of the cannula was
connected to PE-50 polyethylene tubing, which in turn was connected to a syringe
placed in a 10-syringe infusion pump (KD Scientific, Holliston, MA). The size and
schedule of the infusions was computer controlled. Unless stated otherwise, cannulation
was performed 2 hr. prior to fluid infusion.

2.4. Drug Preparation
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Norbinaltorphimine (nor-BNI: selective kappa opioid antagonist: Experiment 2),
Spiradoline mesylate (U62,066E: selective kappa opioid agonist: Experiment 3), and
Tyr-d-Ala-Gly-N-Me-Phe-Gly-ol enkephalin (DAMGO: selective mu opioid agonist:
Experiment 4) (Sigma-Aldrich, St. Louis, MO) were administered via intraperitoneal (i.p.)
injections, as described in Nizhnikov et al., (2006b). Briefly, 30 gauge needles were
used, connected to 1cc tuberculin syringes. The site of the injection was located
approximately halfway between the diaphragm and the genitalia, on the right side of the
pup. Injections were executed in less than 10s. Injection volume was 0.01 ml/g for all
doses and saline (0.9%) was employed as the vehicle solution. Nor-BNI was
administered 24 hours prior to the start of testing to allow for the drug effects to be
selective for kappa opioid receptors (Metcalf and Coop, 2005).
2.5. Infant Fluid Intake Test (Experiments 1 & 2)
The procedures were similar to those used in Chotro et al., (Chotro and Arias,
2006) and Pautassi et al., (2012b). Specifically, two hours prior to each days’ intake test
(Experiment 1: ethanol 5.0%, 10.0%, 20.0% or water; Experiment 2: ethanol 5.0% or
water), pups were removed from the dam, cannulated (described above), and placed in
pairs (1 male and 1 female) in a heated holding chamber. Each pair of animals received
the same type of fluid infusions so that ethanol animals were never with water animals.
Following the 2 hour acclimation period pups were voided by gentle brushing of the
anogenital region and weighed to the nearest 0.01 g. Pups were given intraoral infusion
of either ethanol or water (total volume: 5.5% of body weight, duration of infusion: 15
min) in warmed, individual clear plastic chambers (8 cm × 8 cm × 25 cm). Previous
studies indicate that these infusion parameters allow subjects to ingest or reject the fluid
delivered at will (Pautassi et al., 2002). At the end of the test, subjects were removed,
dried, weighed, had their cannula removed, and either returned to their dams
(Experiment 1) or to a warmed holding cage for 2 hours (Experiment 2). Following the 2
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hours the pups were returned to their dams overnight. Percent body weight gain of fluid
ingested was calculated as follows: ((Pre-test Body Weight – Post-test Body Weight) /
Pre-test Body Weight) * 100.
For Experiment 1 the test occurred on PD14 only. For Experiment 2 rat pups
received a single i.p. injection with one of 3 doses of nor-BNI (0.0 (saline), 2.5 mg/kg, or
10.0 mg/kg) on PD13 and were then immediately returned to their dam for 24 hours. The
intake procedure as described above was then performed for 5 consecutive days
starting on PD14.

2.6. Second-order conditioning and testing (Experiments 3 & 4)
Second-order conditioning (SOC), a variant of place conditioning, was conducted
on postnatal days 14 (first-order conditioning) and 15 (test), as we have done previously
(Pautassi et al., 2012b). SOC allows for the detection of ethanol’s appetitive or aversive
effects across all ages (Molina et al., 2006; Pautassi et al., 2008, 2011), as well as the
pharmacological dissection of these effects (Pautassi et al., 2011; 2012b). The
procedure was composed of three phases (first-order conditioning, second-order
conditioning, and testing):
Phase 1 (first-order conditioning, PD 14): Pups were removed from their dam and
placed in same-sex couples into a heated tub lined with pine shavings. Animals were
immediately cannulated. A habituation phase was conducted 120 min. later, to induce
familiarization with the conditioning chambers. Animals were weighed and then placed
for 10 min into square Plexiglas chambers (10 x 10 x 12 cm) lined with cotton. The
preweanlings were then administered U62,066E (0.0, 1.0, 5.0 or 10.0 mg/kg; Experiment
3) or DAMGO (0.0, 0.1, 1.0 or 5.0 mg/kg; Experiment 4) and returned to their holding
chambers. Conditioning started 5 or 30 minutes following the administration of U62,066E
and DAMGO, respectively. The rationale for delaying conditioning with DAGMO up to 30
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minutes was to allow the peptide to cross the blood-brain barrier; prior studies indicate
that DAMGO enters the brain, albeit slowly [Kin (μl/(g × min) = 0.40 ± 0.55] (Van Dorpe
et al., 2010). During the 15-min conditioning, which occurred in square Plexiglas
chambers with cotton floors, the cheek PE-10 tubing was merged with the PE-50 tubing
previously connected to an infusion pump (KD Scientific, Holliston, MA). The pump
delivered the intraoral conditioned stimulus (CS1), which consisted of fifteen 5 s pulses
(5 µl per pulse; interstimulus interval: 55 s) of distilled water. At termination of
conditioning, the cheek cannula was removed and animals were placed into a warmed
cage lined with wood shavings for 3 h, allowing metabolic processing of the kappa and
mu agonists before reunion with dam and the rest of their littermates.
Phase 2 (second-order conditioning, PD 15): Animals were cannulated and
placed in a warmed cage for 60 min as we have previously done (Pautassi et al.,
2012b). Second-order conditioning then began by placing the subjects into square
chambers similar to those during Phase 1; however, the floor was covered with
sandpaper (50 grit; Gatorgrit, Fairborn, OH). The animals remained in these cages for
four minutes and were given pairings of sandpaper (conditioned stimulus 2, CS2) and
the distilled water CS1. Specifically, distilled water was intraorally infused every 55 s
(volume: 5 µl; pulse duration: 5 s) for 4 min.
Phase 3 (CPP test, PD 15): Thirty minutes after termination of Phase 2, animals
were tested for CS2 preference in a two-way, 5 min tactile preference test. The test

 13  15.5 cm).

began by placing animals in a rectangular Plexiglas chamber (28
floor of the chamber was split in two halves. One half was lined with sandpaper CS2 (50
grit; Gatorgrit) and the other was lined with the smooth backside of a piece of
sandpaper. Both textures were replaced after each test. Textures were selected based
on previous experiments conducted in our lab that demonstrate their effectiveness in
conditioning place preference experiments (e.g., Nizhnikov et al., 2009). An overhead
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40-watt red bulb illuminated the room and time spent in each section of the apparatus
was manually recorded in 1 min bins by an experimenter blind to the conditioning
treatment.
The intermediate section (15% of the entire surface) was considered a neutral
area and not included for data gathering purposes. CS2 preference scores are
expressed as the percent time spent on the rough sandpaper surface. Preference scores
were calculated as follows: (total time spent over sandpaper) / (total time spent over
sandpaper + total time spent over smooth)

 100.

2.7. Tissue Collection and Western Blot Analysis.
Two subjects (one male and one female) from each litter were not tested
behaviorally but sacrificed via decapitation at PD14 and the brain was rapidly removed,
flash frozen and stored at -80OC until further use. The nucleus accumbens (nAc),
hippocampus, amygdala (AMYG), and prefrontal cortex (PFC) were microdissected and
assessed due to their involvement in addiction processes, memory, anxiety, impulse
control, and drug reinstatement. Tissue was processed to determine receptor expression
levels in P2 synaptosomal preparations as described elsewhere (Werner et al., 2011;
Santerre et al., 2013). Briefly, tissue was homogenized in 320 mM sucrose/phosphate
buffered saline (PBS) solution and spun at low speed centrifugation (1,000 x g) and the
subsequent supernatant was then spun again at 12,000 x g for 20 min. The resulting
pellet (P2) was resuspended in PBS. Protein concentrations were quantified using a
bicinchoninic acid method. Protein samples were subjected to SDS–polyacrylamide gel
electrophoresis

using

Novex

Tris–Glycine

(8–16%)

gels

and

transferred

to

polyvinylidene difluoride membranes (Invitrogen, Carlsbad, CA). Membranes were
probed with a primary antibody for the kappa opioid receptor (Millipore, Billerica, MA)
followed by appropriate secondary antibody (Thermo Scientific, Waltham, MA). Bands
were detected using enhanced chemiluminescence (GE Healthcare, Amersham, UK)

13

and exposed to autoradiographic film under nonsaturating conditions. All membranes
were reexposed to β-actin to control for loading. Densitometric analysis was conducted
using NIH Image J software. All samples were assessed in duplicate to triplicate.

2.8. Research Design and Data analysis
Significant main effects or interactions were examined through pair-wise post-hoc
comparisons (Fisher’s Least Mean Significant tests, alpha level set at 0.05). Experiment
1 assessed ethanol intake via a two way Analyses of Variance (ANOVA) and consisted
of a 2 (sex) x 3 (Prenatal Treatment) x 4 (Ethanol concentrations) factorial design.
Experiment 2 analyzed data via a repeated measures ANOVA and consisted of a 2
(sex) x 3 (Prenatal Treatment) x 3 (nor-BNI dose) design. Experiment 3 consisted of a 2
(sex) x 5 (U62,066 dose) design. Experiment 4 used a 2 (sex) x 5 (DAMGO dose)
design. Both experiment 3 and 4 used a two way ANOVA to analyze results. Finally,
Experiment 5 analyzed kappa opioid receptor expression following 2 prenatal treatments
in 4 brain regions and utilized a Student’s t-test to compare untreated and prenatally
ethanol exposed subjects, since preliminary experiments indicated no differences in
kappa opioid expression or ethanol intake between untreated and prenatally water
exposed subjects in Experiment 1.
The dependent variables were ethanol and water intake (percent body weight
gain, %BWG; Experiments 1 and 2), and percent time spent over the sandpaper texture
(Experiments 3 and 4). Kappa opioid receptor expression in specific brain regions was
the dependent variable for Experiment 5.
In order to avoid overrepresentation of litters within each specific group, no more
than 2 animals per litter (one male and one female) were assigned to each particular
treatment. Sex was also considered as a factor; however, since this variable failed to
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exert significant main effects or interact with the remaining factors in all experiments,
data were collapsed across this variable.

3. Results
3.1. Experiment 1: Prenatal ethanol exposure increases subsequent ethanol intake.
Experiment 1 assessed intake of several concentrations of ethanol or water in
PD14 subjects as a function of prenatal treatment (percent body weight gain used as a
measure of fluid intake). Analysis revealed main effects of fluid F(3, 88) = 40.12, p <
0.0001, and prenatal treatment F(2, 88) = 3.89, p < 0.05, as well as a fluid x prenatal
treatment interaction F(6, 88) = 3.20, p < 0.01. All subjects drank less 20% ethanol than
any other fluid. However, animals experiencing prenatal ethanol drank more 5.0%
ethanol than any other prenatal condition group, which did not differ from each other
(Figure 1). No other differences in fluid intake were seen as a function of prenatal
treatment. It seems that the prenatal ethanol exposure protocol used here, albeit much
briefer than

the one employed in other studies (e.g., Zhou et al., 2003), reliably

promotes ethanol intake of a moderately (i.e., 5.0 % v/v) concentrated solution, without
altering overall patterns of fluid intake.

[Insert Figure 1 about here]

3.2. Experiment 2: Kappa opioid receptor activity mediates ethanol intake in controls but
not in animals prenatally exposed to ethanol.
In Experiment 2 the effects of nor-BNI pretreatment (kappa opioid antagonist) on
intake of ethanol or water across 5 days was analyzed as a function of prenatal
treatment. As 5% ethanol concentration elicited robust increases in ethanol intake
following prenatal ethanol exposure, this concentration was used for Experiment 2.
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Preliminary analysis of animals injected with saline on PD13 revealed a main
effect of prenatal treatment (F(2, 26) = 11.48, p < 0.001). Similar to Experiment 1,
Animals exposed to ethanol prenatally exhibited higher ethanol consumption than the
remaining conditions. In view of these baseline differences in ethanol intake and
following the statistical approach employed by Varlinskaya and Spear (2012),
subsequent analyses were conducted separately based on prenatal treatment.
The ANOVA for prenatally untreated animals indicated a main effect of nor-BNI
F(2, 100) = 5.03, p < 0.02, days F(4, 100) = 4.19, p < 0.01 and a nor-BNI x testing day
interaction F(8, 100) = 2.61, p < 0.02. Further analysis indicated a slight, but significant,
increase in ethanol intake on day 1 for animals given the 10 mg/kg nor-BNI dose (se
Figure 2). Animals given both doses of nor-BNI exhibited significantly greater ethanol
intake on days 4 and 5 than animals treated with 0.0 mg/kg nor-BNI.
For prenatally water treated animals, the analysis yielded a main effect of testing day
F(4, 120) = 9.70, p < 0.0001; as well as a nor-BNI x testing day interaction F(8, 120) =
2.07, p < 0.05. Further analysis indicated that the 2.5 mg/kg nor-BNI dose slightly, but
significantly, increased ethanol intake on day 1 of testing. However, a more robust
significant increase in ethanol intake following 2.5 mg/kg nor-BNI administration was
seen on day 5 (Figure 3). A borderline effect was also observed for the 10 mg/kg dose
at both days 1 and 5, but neither reached the level of significance.
The ANOVA for subjects treated prenatally with ethanol only revealed a main
effect of testing day (F(4, 112) = 7.07, p < 0.0001). Ethanol intake was lower on day 2
than on any other test day and this pattern was similar in subjects given either dose of
nor-BNI or vehicle (Figure 4).
Overall, the results from this experiment indicate that the antagonism of kappa
opioid receptors results in increased ethanol intake in control animals, particularly after
repeated exposure to ethanol. This effect may be due to an attenuation of the aversive
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effects of ethanol. Perhaps a more important result was that prenatal ethanol made
animals insensitive to this kappa-mediation of ethanol intake.

[Insert Figure 2 about here]

3.3. Experiment 3: Changes in responding to kappa (U62,066) opioid stimulation as a
function of prenatal ethanol exposure.
Analysis for time spent in contact with the sandpaper CS2 yielded a main effect
of U62 treatment (F4,188 = 2.63, p < 0.05) as well as a U62 treatment x prenatal ethanol
interaction (F8,188 = 2.56, p < 0.05). Further analyses revealed that prenatal vehicle and
prenatal untreated animals given the higher dose of the kappa agonist (10 mg/kg) spent
less time on sandpaper than vehicle or untreated controls. This pattern of results,
depicted in Figure 5, is indicative of U62-induced conditioned place avoidance.
Furthermore, untreated animals also found the moderate dose of U62 (5.0 mg/kg)
aversive. The post-hocs provided no indication of conditioned place avoidance in
prenatally ethanol exposed pups. On the contrary, pups given ethanol in-utero and
conditioned with 5 mg/kg U62 exhibited greater time spent on the sandpaper than
untreated and vehicle-treated counterparts did.
This experiment indicates that prenatal ethanol may significantly alter the
motivational tone of the endogenous kappa opioid system. Activation of this system
induces, as expected, conditioned place avoidance in the offspring of control dams.
Prenatal ethanol disrupted the expression of this conditioned avoidance and even made
animals prefer the kappa-related texture, when the 5 mg/kg dose was employed.

3.4. Experiment 4: Changes in responding to mu (DAMGO) opioid stimulation as a
function of prenatal ethanol exposure.
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Experiment 3 revealed that prenatal ethanol alters the sensitivity to the
motivational consequences of KOR activation, an effect that may underlie the greater
ethanol intake after prenatal exposure. Effects of prenatal exposure on the endogenous
opioid system may be, however, broader, affecting functionality of mu receptors.
Experiment 4 assessed second-order conditioned place preference/aversion, induced by
the administration of the mu agonist DAMGO.
The ANOVA for percent time spent in the DAMO-related sandpaper, indicated
the lack of significant main effects for prenatal exposure or DAMGO treatment. No
significant interactions were observed (see Figure 6).
These results, taken together with those derived from Experiment 3, indicate that
the effects of prenatal ethanol exposure, at this age, may be more dependent on
changes on kappa than on mu opioid receptor function.

Insert Figures 3 and 4 about here

3.5. Experiment 5: Changes in kappa opioid receptor expression as a function of
prenatal ethanol exposure.
Given the involvement of kappa opioid receptors in ethanol intake and the
observed changes in preference for kappa opioid activation following prenatal ethanol
exposure, we wanted to assess whether kappa opioid expression correlated with the
behavioral responses. Compared to controls, we found that prenatal ethanol exposure
reduced synaptosomal kappa opioid receptor expression in the nucleus accumbens by
41.6% (t = 2.494, p < 0.05, Figure 7A), as well as in the amygdala by 47.9% (t = 2.606,
p < 0.05, Figure 7B) and hippocampus by 52.5% (t = 3.259, p < 0.01, Figure 7C). No
differences were found for the prefrontal cortex (Figure 7D).
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Insert Figure 5 about here

4.0. Discussion:
The current set of experiments tested the effects of brief prenatal exposure to
physiologically relevant doses of ethanol during late gestation on ethanol intake, kappa
opioid involvement in ethanol intake, and changes in kappa opioid function and
expression.
The results indicate that relatively low prenatal ethanol exposure significantly
increased drinking of 5.0% ethanol solution and decreased sensitivity to modulation of
ethanol drinking by kappa opioid antagonists. Most strikingly, while control animals
developed conditioned place aversions to textures paired with kappa agonists,
experience with ethanol in the womb resulted in appetitive or neutral responding to
kappa agonists. Changes in motivational responding after prenatal ethanol were specific
to the kappa system, since no change was seen in response to a mu agonist.

Changes in preference for kappa opioid receptor activation were accompanied by
a significant down regulation of kappa opioid receptor expression in brain regions critical
for ethanol responding such as the nucleus accumbens, hippocampus, and amygdala.
These results are especially intriguing since the specific brain areas affected by prenatal
ethanol have been implicated in responding for ethanol. This set of results is consistent
with previous work indicating that prenatal ethanol significantly enhances sensitivity to
ethanol-induced appetitive effects, reduces sensitivity to ethanol-induced aversion
(Pautassi et al., 2012a), and reduces baseline level of activation in the infralimbic area
(Fabio et al., 2013).
Increased intake of ethanol following prenatal exposure has been shown in the
past, and this effect lasts into adolescence (i.e., Diaz-Cenzano and Chotro, 2010; Fabio

19

et al., 2013). However, a thorough analysis of acceptance of different concentrations
following prenatal ethanol exposure has been lacking. Our findings indicate that prenatal
exposure to 1.0 g/kg ethanol during gestational days 17-20 increases the intake of 5.0%
but not 10.0% or 20.0% ethanol solution in PD14 rat pups (Experiment 1).
One possible reason for the increased intake is a change in the pharmacological
reinforcing properties of ethanol following prenatal exposure. We have previously shown
that animals experiencing ethanol prenatally find higher doses of ethanol reinforcing
compared to controls (Nizhnikov et al., 2006a; Pautassi et al., 2012b). Similarly, in the
present study changes in the reinforcing properties of a selective kappa agonist were
attributed to prenatal ethanol. Control subjects found kappa opioid activation aversive, a
result that was expected given that activation of the kappa opioid system has been
shown to mediate the aversive properties of stress (Land et al., 2009) and that kappa
agonists are aversive for adult animals (Mucha and Herz, 1985; Shippenberg and Herz,
1986; Bals-Kubik et al., 1989). Conversely, animals prenatally exposed to alcohol
formed either preference for a texture paired with a kappa agonist or did not form an
aversion (Experiment 3). This set of results suggests that prenatal ethanol induces a
change in the function of the kappa opioid system.
The results of Experiment 4 with DAMGO were surprising given previous work
showing conditioned place preference to central administration of this selective mu
agonist (Bals-Kubik et al., 1993; Madhavan et al., 2010). However, differences in the
route of administration, timing, and age of conditioning likely contribute to the differences
between the above listed studies and ours. Alternatively, DAMGO may have affected the
perception of the CS during the initial conditioning phase.
The kappa opioid system is of special interest with regard to prenatal ethanol
exposure partly because of an established functional switch during normal ontogeny. In
early infancy, activation of the kappa system is appetitive (Varlinskaya et al., 1996;
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Petrov et al., 2006), whereas later in development kappa agonists induce aversion
(Mucha and Herz, 1985; Shippenberg and Herz, 1986; Bals-Kubik et al., 1989). Given
the kappa system’s established involvement in ethanol’s aversive and dysphoric effects
during late infancy and adulthood in non-dependent rats (Matsuzawa et al., 1999;
Mitchell et al., 2005; Logrip et al., 2009), perturbation of this system during a particularly
sensitive and critical developmental period may lead to changes in responding to alcohol
later in life. Specifically, disruption of the kappa system may reduce the aversive
properties of ethanol later in life, leading to increased propensity for use and abuse of
ethanol. The present findings indicate that the switch in kappa opioid function (from
appetitive to aversive) may be either delayed or reversed following prenatal ethanol
exposure.
One possible explanation for the alteration in motivational sensitivity to kappa
activation is that prenatal ethanol changes the expression of kappa opioid receptors in
brain regions intimately related to ethanol responding. We found that kappa opioid
receptor expression was decreased in the nucleus accumbens, amygdala, and
hippocampus, but not the prefrontal cortex. Changes to opioid receptor expression
following exposure to ethanol are not surprising in view of evidence that opioid peptides
and receptors are altered following chronic alcohol exposure (Gianoulakis, 1996;
Turchan et al., 1999; Chen and Lawrence, 2000; Lindholm et al., 2001). In fact, ethanol
exposure has been shown to influence the kappa opioid system specifically. For
example, Rosin et al., (1999) reported that chronic ethanol exposure up-regulates kappa
mRNA levels. Such effects are also suggested by behavioral tests showing that a kappa
opioid antagonist blocks increased ethanol intake only in alcohol-dependent animals
(Walker and Koob, 2008). Taken together, these findings suggest an up-regulation of
kappa opioid receptor expression due to prolonged ethanol exposure.

21

In the present work, decreased kappa expression following low levels of ethanol
exposure seems to contribute to increased ethanol intake. While the underlying
mechanisms for these effects are not clear at present, the previously identified
developmental switch in kappa opioid receptor function during early development may
be involved. These effects may also depend upon dose and duration of ethanol
exposure. Potentially, specific cellular mechanisms such as associations with G proteins
may underlie developmental and prenatal ethanol exposure effects. Furthermore, the
persistence of reductions in kappa opioid function and expression needs to be
investigated.
It is likely that trafficking of synaptosomal kappa opioid receptors also plays a
major role in these effects of ethanol on the kappa opioid system, as has been shown for
other receptors following ethanol exposure (reviewed in: Kumar et al., 2009). In
particular, unpublished observations from our group indicate that total kappa opioid
receptor expression in the nucleus accumbens following the same prenatal ethanol dose
used here, albeit on prenatal day 12, displayed differences from controls. Although total
expression needs to be further validated at the prenatal exposure age used here,
together with the present results, this suggests that prenatal ethanol exposure might
arrest synaptosomal trafficking mechanisms. Also, it is possible that the effects seen in
this set of experiments persists into adolescence or even adulthood. Nonetheless, this is
the first time that prenatal exposure at such low, albeit physiologically relevant, ethanol
levels have been shown to exert such profound effects on kappa opioid function and
expression.
While the current work focuses on the contributions of kappa opioid receptors,
other opioid systems should also be assessed and contributions of non-opioid systems
such as GABA and glutamate should be explored in the present context. While the limbic
system has been a major focus, we cannot rule out changes in ethanol taste preference,
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as previous results indicate increased ethanol palatability following prenatal ethanol
exposure (Arias and Chotro, 2005; Youngentob and Glendinning, 2009; Glendinning et
al., 2012).
Our previous work indicates that the doses used in the present studies do not
produce changes in placenta weight, umbilical cord length, offspring's body weights,
weights and/or size of the olfactory bulbs, cerebral hemispheres, and cerebellum or the
granular layer of the olfactory bulb (Dominguez et al., 1998; Pueta et al., 2011).
However, we cannot rule out that these low levels of prenatal ethanol exposure may
produce other molecular teratological effects. Alternatively, these animals could have
experienced difficulty learning. However, such a possibility is unlikely, given previous
evidence that the present prenatal ethanol treatment does not preclude learning
(Nizhnikov et al., 2006a; Pautassi et al., 2012b). Additionally, the animals in the present
study readily displayed learned preference for a texture paired with a kappa agonist and
were therefore capable of conditioning.
In conclusion, the results presented here add to a growing literature indicating
increased ethanol intake following prenatal ethanol exposure (see: Spear and Molina,
2005) and highlight limbic kappa opioid receptor involvement in the effects of prenatal
ethanol exposure on ethanol intake later in life.
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Figure Captions:
Figure 1. Drinking of several concentrations of ethanol (percentage of body weight gain,
% BWG) as a function of prenatal ethanol treatment (0.0, 1.0 g/kg or no treatment) is
presented. Vertical bars depict means ± S.E.M. The results indicate a significant
increase in drinking of 5.0% ethanol in subjects exposed to ethanol prenatally compared
to controls (F(2,88) = 3.89, p <0.05). Asterisk indicates a significant difference in a given
group from water controls.

Figure 2. Drinking of 5.0% ethanol (percentage of body weight gain, % BWG) as a
function of pretreatment with a kappa opioid antagonist (nor-BNI) in pups derived from
untreated (panel A), prenatally water (panel B), or prenatally ethanol (panel C) treated
dams across 5 days of testing is depicted as means ± S.E.M. The kappa opioid
antagonist nor-BNI was given 24 hours prior to testing). The results indicate a significant
increase in ethanol intake in prenatally untreated subjects for subjects receiving the high
dose of nor-BNI on day 1 and both doses on days 4 and 5 (F(2,100) = 5.03, p<0.02).
Analysis for prenatally water treated animals indicated that the 2.5 mg/kg nor-BNI dose
slightly, but significantly, increased ethanol intake on day 1 of testing. However, a more
robust significant increase in ethanol intake following 2.5 mg/kg nor-BNI administration
was seen on day 5, F(8, 120) = 2.07, p < 0.05. For prenatally ethanol treated subjects no
effect of nor-BNI was seen. Asterisk indicates a significant difference from water
controls.

Figure 3. Percent time spent on a conditioned stimulus (CS+, a sandpaper texture)
associated with the effects of a kappa opioid agonist (U62,066E), as a function of
prenatal treatment (0.0, 1.0 g/kg ethanol, or no treatment) and U62,066E dose (0.0, 1.0,
5.0 or 10.0 mg/kg; or untreated). The results indicate a significant drug x prenatal

32

treatment interaction (F(4, 188) = 2.63, p<0.05). Control subjects (untreated, prenatal
water) displayed aversion to the effects of 5.0 or 10.0 mg/kg U62,066E, while prenatally
ethanol treated pups showed no aversion and even preference for the 5.0 mg/kg dose.
Percent time spent in the CS+ is depicted as means ± S.E.M.

Figure 4. Percent time spent on a conditioned stimulus (CS+, a sandpaper texture)
associated with the effects of a mu opioid agonist (DAMGO), as a function of prenatal
treatment (0.0, 1.0 g/kg or no treatment) and DAMGO dose (0.0, 0.1, 1.0 or 5.0 mg/kg;
or untreated). The results indicate no significant main effects or interactions. Percent
time spent on the CS+ is depicted as means ± S.E.M.

Figure 5. Synaptosomal kappa opioid expression following prenatal ethanol exposure in
the nucleus accumbens (NAc) (A), amygdala (B), hippocampus (C), and prefrontal
cortex (PFC) (D). The results indicate that prenatal ethanol exposure reduced
synaptosomal kappa opioid expression 41-52% in the nucleus accumbens, amygdala
and hippocampus. The prefrontal cortex was unaffected. Representative blots are shown
for each region. Data is presented as mean ± S.E.M. * p < 0.05, n = 5-8 per group.
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